Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - kirk+conrad
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Use of Relaxin as a Therapeutic Agent in Preeclampsia and Other Medical Conditions
Increases the Circulating Number and Activity of Bone Marrow-Derived Endothelial Progenitor Cells Without Causing Inflammation, Offering Potential as a Therapeutic in Cardiovascular DiseaseThis use of the hormone relaxin, relaxin-like peptides or mimetics to positively impact the number and function of bone marrow-derived endothelial progenitor cells...
Published: 6/27/2021
|
Inventor(s):
Mark Segal
,
Kirk Conrad
Keywords(s):
bone marrow derived endothelial cells
,
relaxin
Category(s):
Technology Classifications > Human Health Care
,
Technology Classifications > Human Health Care > Therapeutics
Therapeutic Use of Relaxin to Reduce Risk in Pregnancies Aided by Assisted Reproductive Technologies
Improves Maternal Physiology and Cardiovascular Adaptations During Pregnancy This treatment option provides recombinant relaxin to patients conceiving by Assisted Reproductive Technologies (ART), restoring overall cardiovascular conditions during pregnancy. Assisted reproductive technology aims to obtain pregnancy by way of in vitro fertilization of...
Published: 6/27/2021
|
Inventor(s):
Kirk Conrad
Keywords(s):
Assisted Reproductive Technology
,
Embryo
,
infertility
,
IYF
,
relaxin
,
relaxin mimetic
Category(s):
Technology Classifications > Human Health Care > Therapeutics